5eia
From Proteopedia
(Difference between revisions)
												
			
			| (One intermediate revision not shown.) | |||
| Line 1: | Line 1: | ||
| ==mACHE-anti TZ2PA5 complex from a 1:6 mixture of the syn/anti isomers== | ==mACHE-anti TZ2PA5 complex from a 1:6 mixture of the syn/anti isomers== | ||
| - | <StructureSection load='5eia' size='340' side='right' caption='[[5eia]], [[Resolution|resolution]] 2.70Å' scene=''> | + | <StructureSection load='5eia' size='340' side='right'caption='[[5eia]], [[Resolution|resolution]] 2.70Å' scene=''> | 
| == Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5eia]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EIA OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5eia]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5EIA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5EIA FirstGlance]. <br> | 
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=5O2:6-PHENYL-5-[5-[1-[2-(1,2,3,4-TETRAHYDROACRIDIN-9-YLAMINO)ETHYL]-1,2,3-TRIAZOL-4-YL]PENTYL]PHENANTHRIDIN-5-IUM-3,8-DIAMINE'>5O2</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.7Å</td></tr> | 
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=5O2:6-PHENYL-5-[5-[1-[2-(1,2,3,4-TETRAHYDROACRIDIN-9-YLAMINO)ETHYL]-1,2,3-TRIAZOL-4-YL]PENTYL]PHENANTHRIDIN-5-IUM-3,8-DIAMINE'>5O2</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=PG4:TETRAETHYLENE+GLYCOL'>PG4</scene></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5eia FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5eia OCA], [https://pdbe.org/5eia PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5eia RCSB], [https://www.ebi.ac.uk/pdbsum/5eia PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5eia ProSAT]</span></td></tr> | 
| </table> | </table> | ||
| == Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/ACES_MOUSE ACES_MOUSE] Terminates signal transduction at the neuromuscular junction by rapid hydrolysis of the acetylcholine released into the synaptic cleft. | 
| <div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
| == Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 19: | Line 19: | ||
| </div> | </div> | ||
| <div class="pdbe-citations 5eia" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5eia" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Acetylcholinesterase 3D structures|Acetylcholinesterase 3D structures]] | ||
| == References == | == References == | ||
| <references/> | <references/> | ||
| __TOC__ | __TOC__ | ||
| </StructureSection> | </StructureSection> | ||
| - | [[Category:  | + | [[Category: Large Structures]] | 
| - | [[Category:  | + | [[Category: Mus musculus]] | 
| - | [[Category:  | + | [[Category: Bourne Y]] | 
| - | [[Category:  | + | [[Category: Marchot P]] | 
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
mACHE-anti TZ2PA5 complex from a 1:6 mixture of the syn/anti isomers
| 
 | |||||||||||
